AGING atherosclerotic process. Currently, most studies focus on the association between stroke and Hcy according to Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria [15] [16] [17] [18] , with few and inconsistent conclusions on ICAS involving Hcy. Some studies demonstrated that patients with HHcy had severer stenosis and more arterial lesions in the intracranial arteries [19] [20] [21] . Conversely, a study of 825 stroke patients showed that the positive association of HHcy and burden of large cerebral arteries existed only in the extracranial arteries [22] . Similarly, another study found that HHcy had no effect on extracranial and intracranial large arteries [23] .
Due to the lack of large sample evidence on proatherosclerosis of Hcy involving intracranial arteries, we aim to assess the association between HHcy and ICAS in stroke and non-stroke populations as well as to explore the role of Hcy on the number of ICAS segments in China.
RESULTS

Characteristics of participants
Totally 1731 participants were included in the study, among whom 933(53.90%) were ischemic stroke patients and 798(46.10%) were controls. There were 346 (19.99%) patients and 175 (10.11%) controls with at least one segment of ICAS, while 587 (33.91%) patients and 623 (35.99%) controls were absent of ICAS. Baseline characteristics were illustrated in Table 1 . Compared with controls, patients with acute ischemic stroke were younger and had higher level of total cholesterol (TC), low density lipoprotein (LDL) and serum glucose (GLU), Hcy, blood pressure and higher proportions of male, history of diabetes mellitus, smoking and drinking but lower proportion of coronary heart disease and antihypertensive treatment. In the patients of ischemic stroke, those with ICAS were older and had higher proportions of male, history of hypertension, diabetes mellitus, coronary heart disease, antihypertensive and antidiabetic treatment as well as higher level of GLU, Hcy, while lower proportions of drinking and level of TC, LDL. In the non-stroke controls, those with ICAS were older and had higher proportions of history of hypertension, diabetes mellitus, and antidiabetic treatment as well as higher level of GLU, Hcy and systolic blood pressure.
Association between serum Hcy and ICAS
In unadjusted continuous model, Hcy was significantly associated with ICAS both in stroke patients (OR: 1.03; 95% CI: 1.00-1.06; P=0.044) and controls (OR: 1.10; 95% CI: 1.06-1.14; P<0.001). The adjusted odds ratio of 1 µmol increment in Hcy remained statistically significant in stroke patients (OR: 1.04; 95% CI: 1.01-1.08; P=0.008) and controls (OR: 1.10; 95% CI: 1.06-1.15; P<0.001) ( Table 2) . We further divided all participants into four groups according to quartiles of Hcy concentration. In unadjusted model, Hcy quartiles 3 and 4 were significantly associated with the presence of ICAS both in stroke patients and controls. After having been adjusted for all potential covariates listed in Table 1 Table 2 ).
In addition, participants with more numbers of stenosed intracranial vessels tended to have higher Hcy concentration (P<0.001) and higher percentage of the third and fourth quarter of Hcy distribution (P<0.001) ( Figure 1 ). As for acute ischemic stroke, patients with more than one segment of ICAS had significantly higher Hcy concentration than those with only one segment or absence of ICAS. In non-stroke controls, significant differences were also observed between those with at least one segment of ICAS and individuals with no ICAS (Table 3 ). The Hcy concentration between the anterior and posterior circulation was not significantly different (P=0.546).
DISCUSSION
The principal finding of this study was that elevated Hcy was independently associated with ICAS irrespective of the stroke condition. Moreover, a doseresponse relationship was observed between Hcy concentration and the number of ICAS segments, with higher Hcy correlating with a greater number of ICAS segments.
Previous studies which focused on the association of HHcy and atherosclerosis of large cerebral vessel have obtained conflicting results. Only a few studies conducted in the population of acute cerebral infarction, transient ischemic attack and asymptomatic hypertension, demonstrated that HHcy was associated with advanced intracranial atherosclerosis [19, 24] and the severity of large arteries stenosis [20, 21] . Our findings were largely in line with two previous studies, both of which indicated that HHcy was associated with cerebral arterial stenosis, though the former had limited number of participants, while the latter was conducted in the population of asymptomatic hypertension [21] . Of note, our study strengthened the previous findings that HHcy was associated with the burden of ICAS by establishing a dose-response relationship between HHcy and ICAS. Hence, HHcy plays an essential role in the deterioration of intracranial atherosclerosis. Previous study found that different mechanisms might get involved in the pathogenesis of anterior and posterior circulation ICAS [25] . However, we did not observe significant difference of Hcy between the anterior and posterior ICAS in our data.
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Though potential mechanisms of Hcy for ICAS are not fully understood, one major mechanism is that HHcy activates oxidative stress and its downstream signaling pathways, which subsequently leads to vascular inflammation and endothelial dysfunction [26] [27] [28] [29] [30] . Moreover, a new survey has found that Hcy can directly activate the angiotensin II type I receptor, which plays a significant part in pathological vascular injuries [31] . Compared with extracranial artery, unaffected intracranial arteries have enhanced antioxidant response. However, this antioxidant protection markedly decreases with increased age. Consequently, atherosclerosis of intracranial arteries is faster than that of extracranial arteries [32] . In addition, in pathological condition, intracranial artery might be more susceptible to inflammatory changes owing to reduced expression of inhibitors of inflammation, and prominent expression of proinflammatory proteasomes [33] .
Previous studies reported that HHcy was more common in stroke due to ICAS than other stroke subtypes [9] . And some case-control studies showed that HHcy was not as strong a risk factor for small-vessel stroke or other stroke subtypes as it was for large-artery atherosclerosis subtype [8, 34] . Similarly, some studies indicated that the correlation between Hcy and mortality after stroke or recurrent ischemic stroke was only significant in the large-artery atherosclerosis [15, 16] . All the studies highlighted that Hcy played an essential role in intracranial vascular injury. Our study further supported the role of HHcy in the large cerebral artery atherosclerosis in the population of acute ischemic stroke and non-stroke controls. Therefore, HHcy might be an important marker of vascular injury and a potential target for vascular injury prevention, especially for the intracranial artery.
Limitations
There are some limitations in this study. First, we did not evaluate the role of folate and vitamin B6 / B12 which could influence the level of Hcy and bias the association. Second, only MRA was used to estimate 
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Future directions
More conclusive data from well-designed longitudinal studies and randomized controlled trials are needed to understand the mechanism and long-term effect of Hcy on the ICAS. Moreover, future preclinical studies are needed to determine whether the control of Hcy level is beneficial to vascular injury and the prevention of ischemic stroke, especially those due to ICAS. 
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METHODS
Study design and participants
Participants were prospectively recruited from the Neurology Department and Health & Physical Examination Center of Qingdao Municipal Hospital from January 2014 to June 2018. All are aged over 40 years and have underwent systemic investigations including magnetic resonance imaging (MRI), MRA, and other essential laboratory tests. Acute ischemic stroke is defined as transient ischemic attack (TIA) or MRI confirmed acute ischemic stroke (within 7 days of onset). The non-stroke controls are lack of TIA or acute ischemic stroke that confirmed by neuroimaging. Exclusion criteria included: (1) history of stroke; (2) cardioembolic stroke or evidences of cardioembolic propensity such as history of atrial fibrillation, valvular heart disease and postaortic valve replacement; (3) arterial dissection, arteritis, moyamoya disease and muscle fiber dysplasia; (4) severe stenosis of extracranial carotid artery; (5) serious infection, malignant tumor, chronic liver disease and renal insufficiency. Written informed consents were obtained from all participants or their legal representatives. This study was approved by the Institutional Ethics Committees of Qingdao Municipal Hospital.
Assessment of intracranial arterial stenosis
Images were obtained by a 3D-TOF MRA (TR/TE=20-25/2-3ms, flip angle 15°, FOV=220mm × 220mm, Matrix 320X224, 1.2 mm section thickness and 0.6 mm slice acquisition interval). The presence of ICAS was defined as 50%-99% stenosis according to the Warfarin-Aspirin Symptomatic Intracranial Disease trial criteria [35] or occlusion in at least one of the following arterial segments: proximal portion of the middle (M1/2), anterior (A1/2), or posterior (P1/2) cerebral artery; the basilar artery; or the intracranial portion of the internal carotid artery or vertebral artery (V4). Two experienced radiologists blind to the clinical information independently performed the assessment. Any disagreement was reviewed by a third reader and adjudicated by consensus.
Demographic and clinical measurements
Demographic information, vascular risk factors, history of stroke, alcohol consumption, antihypertensive and antidiabetic treatment were collected by trained and certified neurologists. Vascular risk factors mainly included serum lipid and glucose, blood pressure, hypertension, diabetes mellitus, coronary artery disease, and current and history of smoking. Hypertension was defined as an average systolic blood pressure ≥ 140mmHg, an average diastolic blood pressure ≥ 90mmHg or using antihypertensive drugs [36] ; Diabetes mellitus was defined as an average level of fasting plasma glucose ≥ 7.0mmol/L, or using anti-diabetic medication [37] ; coronary artery disease was defined as a history of coronary artery disease or being newly diagnosed; smoking and drinking were defined as self-reported behaviors of former or current smoking and drinking, respectively.
Laboratory measurement
Venous blood samples were collected within 12 hours of admission and performed in the Central Laboratory of Qingdao Municipal Hospital using the standard protocols measured with automatic biochemical analyzer BECKMAN COULTER AU5800 (Beckman Coulter Inc. Brea, CA, USA), including serum concentrations of total Hcy, TG, TC, high density lipoprotein (HDL), LDL and GLU. 
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CONCLUSIONS
In summary, elevated Hcy is significantly associated with ICAS irrespective of the stroke condition, and there is a dose-response relationship between Hcy concentration and the number of ICAS segments. Therefore, HHcy might be an important marker of vascular injury and a potential target for vascular injury prevention, especially for the intracranial artery.
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